Status:
COMPLETED
Acute Kidney Injury in Patients Hospitalized With COVID-19
Lead Sponsor:
Zhenhua Zen
Conditions:
COVID-19
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
The kidney may be affected in coronavirus-2019 disease (COVID-19). This study assessed the predictors and outcomes of acute kidney injury (AKI) among individuals with COVID-19.
Eligibility Criteria
Inclusion
- COVID-19 pneumonia patients diagnosed by WHO criteria
Exclusion
- Patients who were younger than 18 years,
- Patients who had undergone renal replacement therapy (RRT) before admission,
- Patients whose entire stay lasted for less than 48 hours.
Key Trial Info
Start Date :
February 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 8 2020
Estimated Enrollment :
287 Patients enrolled
Trial Details
Trial ID
NCT04316299
Start Date
February 26 2020
End Date
March 8 2020
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hankou Hospital
Wuhan, Hubei, China, 430000